Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation.
about
IgG4 Characteristics and Functions in Cancer ImmunityHuman IgG4: a structural perspectiveStructural characterization of a human Fc fragment engineered for lack of effector functionsStructural Determinants of Unique Properties of Human IgG4-FcCrystal structure of deglycosylated human IgG4-FcStructure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumabImmune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesThe Fab conformations in the solution structure of human immunoglobulin G4 (IgG4) restrict access to its Fc region: implications for functional activityConstruction of miniantibodies for the in vivo study of human autoimmune diseases in animal modelsComplement therapy in atypical haemolytic uraemic syndrome (aHUS).Improved biodistribution, tumor targeting, and reduced immunogenicity in mice with a gamma 4 variant of Campath-1H.Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1IgG4-related sclerosing disease, an emerging entity: a review of a multi-system diseaseIgG subclasses and allotypes: from structure to effector functions.Transferrin-antibody fusion proteins are effective in brain targetingEffects of rituximab on morphofunctional abnormalities of membranous glomerulopathy.A Case of IgG2 Heavy Chain Deposition Disease in a Patient with Kappa Positive Plasma Cell Dyscrasia.The solution structures of two human IgG1 antibodies show conformational stability and accommodate their C1q and FcγR ligands.Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?Solution conformation of wild-type and mutant IgG3 and IgG4 immunoglobulins using crystallohydrodynamics: possible implications for complement activation.Novel IgG-Degrading Enzymes of the IgdE Protease Family Link Substrate Specificity to Host Tropism of Streptococcus SpeciesThe contribution of allergen-specific IgG to the development of th2-mediated airway inflammationEffect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1.Advances in combating fungal diseases: vaccines on the thresholdIgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury.Influence of IgG Subclass on Human Antimannan Antibody-Mediated Resistance to Hematogenously Disseminated Candidiasis in Mice.Development of a specific system for targeting protein to metallophilic macrophages.Homogeneous immunoconjugates for boron neutron-capture therapy: design, synthesis, and preliminary characterization.Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein.The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseasesRationale for anti-CD200 immunotherapy in B-CLL and other hematologic malignancies: new concepts in blocking immune suppression.Anti-CD20-interferon-β fusion protein therapy of murine B-cell lymphomas.Association between IgG4 Autoantibody and Complement Abnormalities in Systemic Lupus Erythematosus.Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5.From Humoral Theory to Performant Risk Stratification in Kidney Transplantation.The role of B-cells in heart failureHeavy chain deposition disease: an overview.Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.Preferentially immunoglobulin (IgG) subclasses production in primary Sjögren's syndrome patients.Mouse and human FcR effector functions.
P2860
Q26770244-DC60CAF0-F029-419D-88D9-BFA4576C60FCQ26779758-3550BBBE-D029-48B2-983F-CB9D4D613351Q27650876-F1314EA6-F976-473B-AC43-37B4A87DF8FCQ27680566-E1CA8F49-BAFF-4FD5-A414-E977C3D18FB7Q27684440-00E7E376-861F-40EA-8D9C-42FFBDE11C94Q27702872-FF05D621-EF6B-4C1A-86B4-D776D8C206F8Q28069362-BF12929B-A8BC-44EC-A4E2-E1DAA6B7E23DQ30363006-23651D78-D13B-4F61-A500-07EE3CF8C109Q33293219-5B0BBB83-FDF6-4CA4-A850-C9253A46E6F6Q33408733-CBA1876A-2317-4BC3-BEB6-6243B68D9641Q33636882-94A3C48C-E97D-4E6E-8DFB-56C3D4B69225Q33870167-7E25DC83-310C-4E52-9D57-49C0B01E287EQ34242001-F346E683-AA91-454F-AE4F-9D8463E9AC2FQ34368678-539FA3F0-A932-43D3-94FD-55307927ED21Q34506062-2761542D-18F4-48B8-846F-59ED312CE696Q34656882-FFC185FE-B2D8-4D10-BDCA-0DF296E8C7AEQ34958061-4DB37605-0707-4CB6-8A63-B9BB5DE85F3FQ35221593-841EE731-D01A-46DF-B3FC-81BC0167EA34Q35767742-35FE556F-F0D1-43B0-AA0A-D10BE243126AQ36156532-2F34D6B0-EF7D-4118-8531-2ACF2E46F6E7Q36165324-6BB44CFF-328A-4ACD-84B3-8216053492DAQ36361177-0726676A-B976-4028-A7B9-D8BC816EDB23Q36363690-5CC42B3B-E4E6-4959-B3F6-D74E71DC8032Q36406460-918107DF-B30A-47F9-AA83-DE33588B454DQ36417907-3F7646CA-C634-4D82-BDED-FDFBACC8BC02Q36513475-08738B2C-994C-49B2-AEFB-BEB57AEC75D3Q36604283-57DF424F-D169-44F3-9E09-47170E11080EQ36645847-1D1EA6C3-87A9-4F4F-AE53-A8271407908CQ36688075-A0AB4903-0F46-4ACF-AEA1-743484374F36Q36728029-9F8C0D9B-EFE9-40EC-918E-301D88CCE2F0Q37032625-ED87C87B-124B-448E-9BC3-DCE660CA0E7FQ37088489-FC19C1AC-8DA5-4AE0-BA23-C207777F9074Q37202064-0BCEA6D5-AE7D-48CC-A7DC-43FC4EDDA994Q37452067-485F0AD7-700E-4FD5-87A1-75DA4724B5A3Q37590820-E1EED64C-9E30-4111-AEAC-7FA8100CC8F9Q38091933-51D40CB5-DB93-48C3-996B-A85E235E8396Q38104996-AA041DF6-8DB0-4F64-A4DE-8017FC2420F0Q38308978-BE3E0E1D-BEE5-4B5A-8CA6-76713EB4F456Q38407400-E996D52F-06DB-4C49-B4B0-D5D4C5DD8C4BQ38615349-980E4129-C7BF-474F-A667-052F6BCCC7D4
P2860
Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Structural features of human i ...... nces in complement activation.
@ast
Structural features of human i ...... nces in complement activation.
@en
type
label
Structural features of human i ...... nces in complement activation.
@ast
Structural features of human i ...... nces in complement activation.
@en
prefLabel
Structural features of human i ...... nces in complement activation.
@ast
Structural features of human i ...... nces in complement activation.
@en
P2093
P2860
P356
P1476
Structural features of human i ...... nces in complement activation.
@en
P2093
P2860
P304
P356
10.1084/JEM.178.2.661
P407
P577
1993-08-01T00:00:00Z